Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Biomarkers kunnen 'Lewy body'-dementie van Alzheimer onderscheiden
okt 2023 | Dementie